Open AccessThe Quality Assurance Matrix in Pharmaceutical Research and Development. A Personal View
Author(s) -
Long David
Publication year - 1996
Publication title -
the quality assurance journal
Language(s) - English
Resource type - Journals
eISSN - 1099-1786
pISSN - 1087-8378
DOI - 10.1002/(sici)1099-1786(199609)1:1<17::aid-qaj1>3.0.co;2-8
Subject(s) - quality assurance , work (physics) , business , quality (philosophy) , process management , engineering management , matrix (chemical analysis) , computer science , operations management , risk analysis (engineering) , engineering , marketing , mechanical engineering , chemistry , physics , chromatography , quantum mechanics , service (business)
When determining the place of Quality Assurance groups within companies, management uses arguments to defend their preferred structures. These are typically the ‘vertical’ structure and the ‘site‐based’ structure. In this article the author defends the situation that since Quality Assurance Professionals perform essentially similar work throughout the GXP scenario in Pharmaceutical R&D, a matrix approach is the most suitable to meet their principle functions.